Capecitabine/Oxaliplatin/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of capecitabine, oxaliplatin, and trastuzumab that may be used in the treatment of esophageal and esophagogastric junction and gastric cancers. Low-dose capecitabine/oxaliplatin/trastuzumab regimen may be used for the treatment of gastric, esophageal and esophagogastric junction cancers.

**Synonyms:** - CAPOX-Trastuzumab - CapeOx and Trastuzumab - CapeOx and Trastuzumab-anns - CapeOx and Trastuzumab-dkst - CapeOx and Trastuzumab-dttb - CapeOx and Trastuzumab-herw - CapeOx and Trastuzumab-pkrb - CapeOx and Trastuzumab-qyyp - CapeOx and Trastuzumab-strf - CapeOx and Trastuzumab-zerc - CapeOx/Trastuzumab - Capecitabine-Oxaliplatin-Trastuzumab - Capecitabine/Oxaliplatin/Trastuzumab - Xeloda/Eloxatin/Herceptin